How Buccal and Sublingual Peptide Delivery Evidence Should Be Translated Across Research Models

Buccal and sublingual peptide delivery evidence should be translated across research models by asking what each system actually measures. Cell cultures, synthetic membranes, excised oral mucosa, animal studies, and human pharmacokinetic research represent different levels of biological complexity, so a favorable result in one model should be treated as evidence for that model rather than automatic proof of equivalent human peptide absorption.

Within buccal and sublingual peptide delivery research, experimental models are used because no single system can answer every formulation question efficiently. Researchers may begin with release testing, move into cultured epithelial systems or excised mucosal tissue, evaluate selected formulations in animals, and eventually investigate systemic exposure in people. Translation becomes stronger when each stage answers a clearly defined question.

Research-use notice: InStrips products are intended solely for research and analytical use. This article examines how buccal and sublingual peptide delivery evidence should be translated across laboratory, tissue, animal, and human research models and does not present experimental peptide-delivery findings as products for diagnosing, treating, curing, or preventing any medical condition.

Each Research Model Represents a Different Level of Complexity

Experimental systems commonly used in oral mucosal delivery research include:

• synthetic membranes
• cell-culture models
• excised animal mucosa
• excised human mucosa
• living animal models
• human pharmacokinetic studies

These approaches are related, but they are not interchangeable.

A synthetic membrane may help compare diffusion between formulations. Excised tissue adds a biological barrier. An animal study adds saliva, circulation, metabolism, and movement. A human study adds the anatomy and physiology ultimately relevant to human exposure.

Early Models Are Useful Because They Simplify the Problem

Formulation development often begins with controlled laboratory systems because researchers can isolate individual variables.

They may ask:

• How rapidly does peptide leave the formulation?
• Does a polymer change release?
• Does an enhancer increase transport?
• Does peptide remain intact during the experiment?

A simplified system can answer these questions more cleanly than a whole-animal or human experiment.

Simplification Also Creates Translational Limits

The same control that makes a laboratory model useful also removes physiological variables.

A diffusion chamber may not reproduce:

• continuous saliva production
• swallowing
• blood flow
• mouth movement
• variable film contact

A formulation that performs strongly under fixed conditions may therefore perform differently in vivo.

Cell Models Can Help Investigate Epithelial Transport

Human-derived oral epithelial cell systems can provide standardized barriers for repeated experiments.

They are useful for studying:

• relative permeability
• cellular transport
• enzyme activity
• barrier effects of formulation components

Because cells can be cultured under reproducible conditions, they can reduce some of the biological variability found in excised tissue.

Cell Culture Is Not Complete Oral Mucosa

A cultured epithelial layer generally lacks the complete organization of native mucosa.

It may differ in:

• epithelial thickness
• intercellular lipid composition
• enzyme expression
• underlying connective tissue
• blood supply

These differences can influence peptide transport.

Peptide Metabolism Can Differ Between Models

Studies using the TR146 human buccal cell model, human buccal epithelium, and porcine buccal epithelium have shown that enzyme activity can differ among experimental systems.

This matters because peptides can be degraded by mucosal peptidases before they cross the barrier.

A permeability model that reproduces transport reasonably well may still reproduce peptide metabolism less accurately.

Excised Tissue Adds Native Barrier Architecture

Ex vivo mucosal tissue preserves features that cultured cells cannot reproduce fully.

These include:

• stratified epithelium
• native extracellular structure
• endogenous enzymes
• more realistic tissue thickness

This makes excised tissue particularly useful for formulation screening.

Porcine Buccal Mucosa Is Commonly Used for a Reason

Pig oral mucosa shares several structural characteristics with human non-keratinized oral tissue.

Porcine buccal tissue is therefore widely used as an experimental model for transbuccal delivery.

Recent peptide-film research continues to use porcine oromucosa as a preclinical screening system before advancing promising formulations into pharmacokinetic studies.

Porcine Tissue Is Still a Model, Not Human Tissue

Similarity does not mean identity.

Species can differ in:

• epithelial thickness
• lipid organization
• enzyme activity
• regional permeability

A permeability value measured in pig tissue should therefore not be converted directly into a predicted human bioavailability percentage.

Tissue Region Can Matter Within the Same Animal

Research using porcine buccal mucosa has shown significant permeability differences between tissue collected near the lip and tissue from the cheek region.

The cheek region had a thicker epithelium and lower permeability for the model compounds studied.

This demonstrates that species identification alone is not enough.

Researchers also need to report the anatomical region sampled.

Tissue Thickness Can Change Transport Results

Buccal mucosa contains both epithelium and underlying connective tissue.

Research has shown that increasing total tissue thickness can reduce measured permeability and increase lag time.

The epithelial layer is generally the primary permeability barrier, but excessive connective tissue can introduce additional resistance in an ex vivo experiment.

Full-Thickness and Epithelial Preparations Should Not Be Compared Casually

One experiment may use:

• full-thickness mucosa
• partially trimmed tissue
• isolated epithelium

Those preparations create different diffusion distances.

Cross-study comparisons should identify this difference before comparing flux values.

Tissue Storage Can Alter Barrier Integrity

Excised tissue begins changing after collection.

Storage variables may include:

• temperature
• storage solution
• time before experimentation
• freezing

Research with porcine buccal tissue has demonstrated that storage conditions can affect epithelial integrity and therefore measured permeability.

Higher Permeability Can Sometimes Reflect Tissue Damage

An unusually permeable tissue preparation does not necessarily represent a superior delivery system.

The barrier may simply have been compromised.

Tissue-integrity testing is therefore important when interpreting large increases in peptide flux.

Human Ex Vivo Tissue Adds Relevance but Does Not Eliminate Experimental Limitations

Human tissue can reduce uncertainty related to species differences.

However, excised human mucosa still lacks:

• blood flow
• normal salivary dynamics
• living systemic metabolism
• behavioral variables

It also introduces donor-to-donor variability.

Human Tissue Availability Can Limit Sample Size

Access to suitable oral mucosal tissue can be restricted.

Samples may differ according to:

• donor age
• collection site
• tissue condition
• processing time

This can make standardized animal models useful even when human tissue would appear more directly relevant.

Animal In Vivo Models Add Physiological Processes

A living-animal model introduces:

• blood circulation
• salivary flow
• systemic distribution
• metabolism
• whole-body pharmacokinetics

This provides a more complete translational step than excised tissue alone.

Animal Oral Anatomy Still Differs From Human Anatomy

Differences may occur in:

• oral cavity dimensions
• mucosal thickness
• keratinization
• salivary secretion
• film-retention behavior

A film that stays attached reliably in one species may behave differently in people.

Buccal and Sublingual Models Should Not Be Merged

The cheek and floor of the mouth have different barrier properties.

Even within the same species, sublingual or mouth-floor tissue can be more permeable than buccal tissue.

A study performed with one region should not automatically be described as evidence for the other.

Human Pharmacokinetics Provide the Most Direct Translation for Systemic Delivery

When the goal is systemic peptide exposure, human studies can measure:

• Cmax
• Tmax
• AUC
• relative bioavailability
• absolute bioavailability when an appropriate reference exists

These outcomes answer questions that tissue permeation experiments cannot resolve completely.

Human Results Can Be Used to Judge the Earlier Models

Translation does not move in only one direction.

Once human exposure data become available, researchers can compare those results with:

• cell permeability
• ex vivo flux
• animal pharmacokinetics

This helps identify which experimental model was most predictive.

A Good Model Does Not Need to Reproduce Every Human Detail

The purpose of a model is usually to answer a particular research question.

A model may be useful if it reliably ranks formulations even when its absolute permeability values differ from humans.

Predictive ranking can be more useful during formulation screening than perfect numerical matching.

Translation Should Be Stepwise Rather Than Automatic

A defensible evidence chain might look like:

• film releases intact peptide
• peptide crosses an epithelial model
• transport reproduces in excised mucosa
• the formulation produces systemic exposure in vivo
• human pharmacokinetics confirm exposure

Each step strengthens the next without replacing it.

Negative Translation Is Also Informative

A formulation may show strong ex vivo transport but limited in vivo exposure.

That difference can reveal previously underestimated variables such as:

• salivary washout
• peptide metabolism
• insufficient residence time
• film displacement

Failure to translate can therefore improve the experimental model.

Model Selection Should Match the Question

The strongest research design asks:

Which model is appropriate for the specific step being studied?

A release experiment does not need a whole animal.

A human bioavailability claim cannot be established with a synthetic membrane.

Tissue Source Is One of the Most Important Translation Variables

The influence of anatomical region, species, processing, and tissue thickness is examined further in why oral mucosal tissue source can change peptide transport results.

Final Perspective

Buccal and sublingual peptide-delivery evidence becomes strongest when experimental models are treated as stages of translation rather than interchangeable substitutes. Cell systems provide controlled epithelial experiments. Excised mucosa introduces native barrier architecture. Animal studies add living physiology. Human studies provide the most direct evidence about human systemic exposure.

No single model needs to answer every question. The important requirement is to preserve the boundaries of what each system can establish.

Translational confidence increases when a finding survives progressively more realistic models and ultimately corresponds with human exposure rather than when a promising result from one laboratory system is generalized directly to people.